JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1981) 89, 91-98    DOI: 10.1677/joe.0.0890091
© 1981 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RUSSELL, J. A.
Right arrow Articles by McNEILLY, A. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by RUSSELL, J. A.
Right arrow Articles by McNEILLY, A. S.

BROMOCRIPTINE AND {alpha}-ERGOCRYPTINE DO NOT INHIBIT OXYTOCIN SECRETION IN THE LACTATING RAT

J. A. RUSSELL, D. J. HARRISON and A. S. McNEILLY

Two experiments were performed to study the effects of bromocriptine and {alpha}-ergocryptine on oxytocin secretion in lactating rats. In both experiments, after overnight separation from their litters, rats were injected with either vehicle alone or ergot alkaloid plus vehicle; 4 h later the litters were returned.

In the first experiment the mothers were conscious. Treatment did not affect suckling behaviour, number of stretch reactions or litter weight gain in the first 30 min. Oxytocin injection before the second 30 min period of suckling caused no extra milk to be obtained. In the second experiment the mothers were anaesthetized with ethyl carbamate (1·1 g/kg body weight) at the time of the ergot alkaloid or vehicle injection. Changes in intramammary pressure were recorded during suckling. Ergot alkaloids altered neither the number of milk ejections caused by suckling, nor the proportion of milk ejections equivalent to 0·2 mu. or more oxytocin.

In both experiments treatment with ergot alkaloids suppressed secretion of prolactin. It is concluded that (a) in suppressing lactation, bromocriptine and {alpha}-ergocryptine do not inhibit oxytocin secretion as well as prolactin secretion, and that (b) prolactin secretion is not a necessary concomitant of oxytocin secretion.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the Society for Endocrinology.